Castillo JM, Vargas F, Arenas R, Vega MME, Benuto RE

Idioma: Español
Referencias bibliográficas: 16
Paginas: 253-257
Archivo PDF: 306.26 Kb.

RESUMEN

Se presenta un caso de epidermodisplasia verruciforme en una mujer de 14 años de edad con lesiones diseminadas tipo verrugas planas y placas eritematosas e hipocrómicas que semejan pitiriasis versicolor de cinco años de evolución. La histopatología fue compatible y el PCR detectó VPH-11, un virus de bajo potencial oncogénico.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Androphy E, Lowy D. Warts. En: Wolff K, Goldsmith L, Katz S. et al. Fitzpatrick´s Dermatology in General Medicine. 7th. ed. McGraw-Hill New York 2003 p. 1914-1923.

2. Rogers H, McGregor J, Nord K. et al. “Acquired epidermodysplasia verruciformis”. J Am Acad Dermatol 2009; 60: 315-320.

3. Crespo G, Llanos L, Pam Pino A. “Epidermodisplasia verruciforme, reporte de un caso”. Archivo Médico de Camagüey 2004; 8(4): 1-5.

4. Ponce R, Peniche J, Tirado A. et al. “Epidermodisplasia verruciforme, modelo de carcinogénesis viral”. Dermatología Rev Mex 2006; 50: 83-86.

5. García V, Rodríguez M, Alonso M. et al. “Epidermodisplasia verru - ciforme, comunicación de un caso”. Rev Cent Dermatol Pascua 2003; 12(1): 34-37.

6. Berthelot C, Dickerson M, Rady P. et al. “Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod” J Am Acad Dermatol 2007; 56(5): 82-87.

7. Ramagosa R, de Villiers E, Fitzpatrick J. et al. “Human papillomavirus infection and ultraviolet light exposure as epidermoid inclusion cyst risk factors in a patient with epidermodysplasia verruciformis?” J Am Acad Dermatol 2008; 58: S68.

8. Vidal L, Gillison M. “Human Papillomavirus in HNSCC: Recog - nition of a Distinct Disease Type Hematol”. Oncol Clin N Am 2008; 22: 1125-1142.

9. Kreuter A, Hochdorfer B, Brockmeyer NH, Altmeyer P, Pfister H, Wieland U. “A human papillomavirus-associated disease with disseminated warts, depressed cell-mediated immunity, primary lymphedema, and anogenital dysplasia: WILD syndrome”. Arch Dermatol. 2008; 144(3): 366-372.

10. Shimizu M, Adachi A, Zheng S, Matsunaga J, Kusakari Y, Tagami H, Nagasaka T, Tomita Y. “Detection of various types of human papillomavirus DNA, mainly belonging to the cutaneous-group, more frequently in normal tissue than in squamous cell carcinomas of the lip”. J Dermatol Sci 2004; 36(1): 33-39.

11. Zheng S, Adachi A, Shimizu M, Shibata SI, Yasue S, Sakakibara A, Sugiura M, Nagasaka T, Tomita Y. “Human papillomaviruses of the mucosal type are present in some cases of extragenital Bowen’s disease”. Br J Dermatol 2005; 152(6): 1243-1247.

12. Biliris KA, Koumantakis E, Dokianakis DN, Sourvinos G, Spandidos DA. “Human papillomavirus infection of non-melanoma skin cancers in immunocompetent hosts”. Cancer Lett 2000; 161(1): 83-88.

13. Kunishige J, Hymes S, Madkan V. et al. “Epidermodysplasia verruciformis in the setting of graft-versus-host disease” J Am Acad Dermatol 2007; 57: 78-80.

14. Carlson J, Cribier B. “Epidermodysplasia verruciformis associated and genital-mucosal high-risk human papillomavirus DNA are prevalent in nevus sebaceus of Jadassohn” J Am Acad Dermatol 2008; 59: 279-294.

15. Cortés-Franco R, Stephen K, Vega-Memije M E, Payne D, Granados J, Domínguez-Soto L. “Divergent clinic course of epidermodysplasia verruciforme in siblings”. Int J Dermatol 1997; 36: 435-452.

16. Kottke M, Sareeta R. “Intravenous cidofovir-induced resolution of disfiguring cutaneous human papillomavirus infection” J Am Acad Dermatol 2006; 55: 533-536.